Previous Article | Next Article 
J Virol, August 1998, p. 6389-6397, Vol. 72, No. 8
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
The Cytomegalovirus-Encoded Chemokine Receptor US28 Can
Enhance Cell-Cell Fusion Mediated by Different Viral
Proteins
Olivier
Pleskoff,
Carole
Tréboute, and
Marc
Alizon*
INSERM U.332, Institut Cochin de
Génétique Moléculaire, 75014 Paris, France
Received 11 February 1998/Accepted 28 April 1998
The human cytomegalovirus (CMV) US28 gene encodes a
functional CC chemokine receptor. However, this activity was observed in cells transfected to express US28 and might not correspond to the
actual role of the protein in the CMV life cycle. Expression of US28
allows human immunodeficiency virus type 1 (HIV-1) entry into certain
CD4+ cells and their fusion with cells expressing HIV-1
envelope (Env) proteins. Such properties were initially reported for
the cellular chemokine receptors CCR5 and CXCR4, which behave as
CD4-associated HIV-1 coreceptors. We found that coexpression of
US28 and either CXCR4 or CCR5 in CD4+ cells resulted
in enhanced synctium formation with HIV-1 Env+ cells. This
positive effect of US28 on cell fusion seems to be distinct from its
HIV-1 coreceptor activity. Indeed, enhancement of cell fusion was also
observed when US28 was expressed on the HIV-1 Env+ cells
instead of an CD4+ target cells. Furthermore, US28
could enhance cell fusion mediated by other viral proteins, in
particular, the G protein of vesicular stomatitis virus (VSV-G). The
HIV-1 coreceptor and fusion-enhancing activities could be affected by
mutations in different domains of US28. The fusion-enhancing activity
of US28 seems to be cell type dependent. Indeed, cells
coexpressing VSV-G and US28 fused more efficiently with human, simian,
or feline target cells, while US28 had no apparent effect on fusion
with the three mouse or rat cell lines tested. The positive effect of
US28 on cell fusion might therefore require its interaction with a
cell-specific factor. We discuss a possible role for US28 in the fusion
of the CMV envelope with target cells and CMV entry.
*
Corresponding author. Mailing address: INSERM U.332,
Institut Cochin de Génétique Moléculaire, 22 rue
Méchain, 75014 Paris, France. Phone: 33-1-40 51 64 86. Fax:
33-1-40 51 77 49. E-mail: alizon{at}cochin.inserm.fr.

Present address: Laboratoire de Virologie, Ecole Normale
Supérieure, Lyon, France.
J Virol, August 1998, p. 6389-6397, Vol. 72, No. 8
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Richter, R., Casarosa, P., Standker, L., Munch, J., Springael, J.-Y., Nijmeijer, S., Forssmann, W.-G., Vischer, H. F., Vakili, J., Detheux, M., Parmentier, M., Leurs, R., Smit, M. J.
(2009). Significance of N-Terminal Proteolysis of CCL14a to Activity on the Chemokine Receptors CCR1 and CCR5 and the Human Cytomegalovirus-Encoded Chemokine Receptor US28. J. Immunol.
183: 1229-1237
[Abstract]
[Full Text]
-
Bar, S., Takada, A., Kawaoka, Y., Alizon, M.
(2006). Detection of Cell-Cell Fusion Mediated by Ebola Virus Glycoproteins. J. Virol.
80: 2815-2822
[Abstract]
[Full Text]
-
Zhen, Z., Bradel-Tretheway, B., Sumagin, S., Bidlack, J. M., Dewhurst, S.
(2005). The Human Herpesvirus 6 G Protein-Coupled Receptor Homolog U51 Positively Regulates Virus Replication and Enhances Cell-Cell Fusion In Vitro. J. Virol.
79: 11914-11924
[Abstract]
[Full Text]
-
Latchney, L. R., Fallon, M. A., Culp, D. J., Gelbard, H. A., Dewhurst, S.
(2004). Immunohistochemical Assessment of Fractalkine, Inflammatory Cells, and Human Herpesvirus 7 in Human Salivary Glands. J. Histochem. Cytochem.
52: 671-682
[Abstract]
[Full Text]
-
Penfold, M. E. T., Schmidt, T. L., Dairaghi, D. J., Barry, P. A., Schall, T. J.
(2003). Characterization of the Rhesus Cytomegalovirus US28 Locus. J. Virol.
77: 10404-10413
[Abstract]
[Full Text]
-
Pastore, C., Picchio, G. R., Galimi, F., Fish, R., Hartley, O., Offord, R. E., Mosier, D. E.
(2003). Two Mechanisms for Human Immunodeficiency Virus Type 1 Inhibition by N-Terminal Modifications of RANTES. Antimicrob. Agents Chemother.
47: 509-517
[Abstract]
[Full Text]
-
Lawn, S. D., Butera, S. T., Folks, T. M.
(2001). Contribution of Immune Activation to the Pathogenesis and Transmission of Human Immunodeficiency Virus Type 1 Infection. Clin. Microbiol. Rev.
14: 753-777
[Abstract]
[Full Text]
-
Beisser, P. S., Laurent, L., Virelizier, J.-L., Michelson, S.
(2001). Human Cytomegalovirus Chemokine Receptor Gene US28 Is Transcribed in Latently Infected THP-1 Monocytes. J. Virol.
75: 5949-5957
[Abstract]
[Full Text]
-
Fraile-Ramos, A., Kledal, T. N., Pelchen-Matthews, A., Bowers, K., Schwartz, T. W., Marsh, M.
(2001). The Human Cytomegalovirus US28 Protein Is Located in Endocytic Vesicles and Undergoes Constitutive Endocytosis and Recycling. Mol. Biol. Cell
12: 1737-1749
[Abstract]
[Full Text]
-
de Parseval, A., Elder, J. H.
(2001). Binding of Recombinant Feline Immunodeficiency Virus Surface Glycoprotein to Feline Cells: Role of CXCR4, Cell-Surface Heparans, and an Unidentified Non-CXCR4 Receptor. J. Virol.
75: 4528-4539
[Abstract]
[Full Text]
-
Sabbe, R., Picchio, G. R., Pastore, C., Chaloin, O., Hartley, O., Offord, R., Mosier, D. E.
(2001). Donor- and Ligand-Dependent Differences in C-C Chemokine Receptor 5 Reexpression. J. Virol.
75: 661-671
[Abstract]
[Full Text]
-
Murphy, P. M., Baggiolini, M., Charo, I. F., Hebert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., Power, C. A.
(2000). International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors. Pharmacol. Rev.
52: 145-176
[Abstract]
[Full Text]
-
Bodaghi, B., Slobbe-vanDrunen, M. E. P., Topilko, A., Perret, E., Vossen, R. C. R. M., van Dam-Mieras, M. C. E., Zipeto, D., Virelizier, J.-L., LeHoang, P., Bruggeman, C. A., Michelson, S.
(1999). Entry of Human Cytomegalovirus into Retinal Pigment Epithelial and Endothelial Cells by Endocytosis. IOVS
40: 2598-2607
[Abstract]
[Full Text]
-
Beisser, P. S., Grauls, G., Bruggeman, C. A., Vink, C.
(1999). Deletion of the R78 G Protein-Coupled Receptor Gene from Rat Cytomegalovirus Results in an Attenuated, Syncytium-Inducing Mutant Strain. J. Virol.
73: 7218-7230
[Abstract]
[Full Text]
-
Hunninghake, G. W., Monick, M. M., Geist, L. J.
(1999). Cytomegalovirus Infection . Regulation of Inflammation. Am. J. Respir. Cell Mol. Bio.
21: 150-152
[Full Text]
-
Zipeto, D, Bodaghi, B, Laurent, L, Virelizier, J., Michelson, S
(1999). Kinetics of transcription of human cytomegalovirus chemokine receptor US28 in different cell types. J. Gen. Virol.
80: 543-547
[Abstract]
-
Gordon, C. J., Muesing, M. A., Proudfoot, A. E. I., Power, C. A., Moore, J. P., Trkola, A.
(1999). Enhancement of Human Immunodeficiency Virus Type 1 Infection by the CC-Chemokine RANTES Is Independent of the Mechanism of Virus-Cell Fusion. J. Virol.
73: 684-694
[Abstract]
[Full Text]
-
Brelot, A., Heveker, N., Montes, M., Alizon, M.
(2000). Identification of Residues of CXCR4 Critical for Human Immunodeficiency Virus Coreceptor and Chemokine Receptor Activities. J. Biol. Chem.
275: 23736-23744
[Abstract]
[Full Text]
-
Casarosa, P., Bakker, R. A., Verzijl, D., Navis, M., Timmerman, H., Leurs, R., Smit, M. J.
(2001). Constitutive Signaling of the Human Cytomegalovirus-encoded Chemokine Receptor US28. J. Biol. Chem.
276: 1133-1137
[Abstract]
[Full Text]